semaglutide stinging at injection site Reaction Ozempic Burning at Injection Site:

What are the possible side effects of Tesamorelin

DOI:10.4103/1673-5374.320969

RESEARCH presented at ACR Convergence 2025 highlights a potential new role for GLP-1 receptor agonists, medications widely used for type 2 diabetes and obesity, in the treatment of rheumatoid arthritis (RA)

It is difficult to consider some confounders (such as dosage, duration of use, comorbidities, and drug combinations) that may influence the occurrence of gastrointestinal toxicity

The MHRA update is simply a reminder that powerful drugs require powerful vigilance, and until we have larger, long-duration real-world safety data, clinicians should err on the side of specificity in monitoring and patients should be taught exactly what to look for. Hector Perez, MD

Lifestyle & Environmental factors behind the epidemic of obesity